Characteristics of HIV epidemics driven by men who have sex with men and people who inject drugs

Current Opinion in HIV and AIDS

Volumn 6, Issue 2, 2011, Pages 94-101

  Wilson, David P ^a,b   Zhang, Lei ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NONE   (Australia)

Author keywords

HIV; Mathematical modelling; Men who have sex with men; People who inject drugs

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONDOM; EPIDEMIC; HARM REDUCTION; HIV TEST; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MALE HOMOSEXUAL; MATHEMATICAL MODEL; NEEDLE; PRIORITY JOURNAL; RISK REDUCTION; SAFE SEX; SYRINGE; VIRUS LOAD;

DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MODELS, STATISTICAL; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 79951768186     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e328343ad93     Document Type: Article

References (106)

1. UNAIDS, Global report: UNAIDS report on the global AIDS epidemic 2010. 2010, UNAIDS: Washington.
2. Bridge J, Lazarus JV, Atun R. HIV epidemics and prevention responses in Asia and Eastern Europe: lessons to be learned? AIDS 2010; 24 (Suppl 3):S86-S94.
3. (Pubitemid 38976486)
4. Weniger BG, Limpakarnjanarat K, Ungchusak K, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS 1991; 5 (Suppl 2):S71-S85.
5. van Griensven F, van Wijngaarden JW, Baral S, Grulich AE. The global epidemic of HIV infection among men who have sex with men. Curr Opin HIV AIDS 2009; 4:300-307.
6. Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372:1733-1745.
7. Bogaert AF. The prevalence of male homosexuality: the effect of fraternal birth order and variations in family size. J Theor Biol 2004; 230:33-37. (Pubitemid 38951126)
8. AIDS and sexual behaviour in France. ACSF investigators. Nature 1992; 360:407-409.
9. Billy JO, et al. The sexual behavior of men in the United States. Fam Plann Perspect 1993; 25:52-60. (Pubitemid 23115466)
10. Binson D, et al. Prevalence and social distribution of men who have sex with men: United States and its urban centers. J Sex Res 1995; 32:245-254.
11. Fay RE, Turner CF, Klassen AD, Gagnon JH. Prevalence and patterns of same-gender sexual contact among men. Science 1989; 243:338-348. (Pubitemid 19047508)
12. Johnson AM, Wadsworth J, Wellings K, et al. Sexual lifestyles and HIV risk. Nature 1992; 360:410-412.
13. Jaffe HW, Valdiserri RO, De Cock KM. The reemerging HIV/AIDS epidemic in men who have sex with men. J Am Med Assoc 2007; 298:2412-2414. (Pubitemid 350190783)
14. Grulich AE, Kaldor JM. Trends in HIV incidence in homosexual men in developed countries. Sex Health 2008; 5:113-118. (Pubitemid 351786444)
15. Likatavicius G, Klavs I, Devaux I, et al. An increase in newly diagnosed HIV cases reported among men who have sex with men in Europe 2000-6: implications for a European public health strategy. Sex Transm Infect 2008; 84:499-505.
16. HIV, viral hepatitis and sexually transmissible infections in Australia. Annual Surveillance Report. 2009, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales: Sydney, Australia.
17. McAllister SM, Dickson NP, Sharples K, et al. Unlinked anonymous HIV prevalence among New Zealand sexual health clinic attenders: 2005-2006. Int J STD AIDS 2008; 19:752-757.
18. de Lind van Wijngaarden JW, Brown T, Girault P, et al. The epidemiology of human immunodeficiency virus infection, sexually transmitted infections, and associated risk behaviors among men who have sex with men in the Mekong Subregion and China: implications for policy and programming. Sex Transm Dis 2009; 36:319-324.
19. van Griensven F. Men who have sex with men and their HIV epidemics in Africa. AIDS 2007; 21:1361-1362. (Pubitemid 46883492)
20. Caceres CF, Konda K, Segura ER, Lyerla R. Epidemiology of male same-sex behaviour and associated sexual health indicators in low- and middle-income countries: 2003-2007 estimates. Sex Transm Infect 2008; 84 (Suppl 1): i49-i56.
21. Jia M, Luo H, Ma Y, et al. The HIV epidemic in Yunnan Province, China, 1989-2007. J Acquir Immune Defic Syndr 2010; 53 (Suppl 1):S34-S40.
22. Chow EP, Wilson DP, Zhang L. The next era of HIV in China: rapidly spreading epidemics among men who have sex with men. J Acquir Immune Defic Syndr 2010; 55:e32-e33; author reply e33-4.
23. National Center for AIDS/STD Control and Prevention. Annual report on HIV/AIDS/STD epidemiology, prevention and treatment in China in 2009. 2010, China CDC: Beijing, China.
24. Center for Health Protection, department of Health. Hong Kong: AIDS Office. Virtual AIDS Office of Hong Kong. surveillance/off-surreport.htm [Accessed 30 November 2010].
25. Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000- 2006: a systematic review. PLoS Med 2007; 4:e339.
26. Jin F, Jansson J, Law M, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 2010; 24:907-913.
27. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 2010.
28. Vittinghoff E, Douglas J, Judson F, et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999; 150:306-311. (Pubitemid 29344958)
29. Henderson DK, Fahey BJ, Willy M, et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med 1990; 113:740-746. (Pubitemid 20369661)
30. Cavalcante NJ, Abreu ES, Fernandes ME, et al. Risk of healthcare professionals acquiring HIV infection in Latin America. AIDS Care 1991; 3:311-316.
31. Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among healthcare personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 1994; 170:1410-1417.
32. Ippolito G, Puro V, De Carli G. The risk of occupational human immunodeficiency virus infection in healthcare workers. Italian Multicenter Study. The Italian Study Group on Occupational Risk of HIV infection. Arch Intern Med 1993; 153:1451-1458. (Pubitemid 23191052)
33. Nelsing S, Nielsen TL, Nielsen JO. Occupational exposure to human immunodeficiency virus among healthcare workers in a Danish hospital. J Infect Dis 1994; 169:478. (Pubitemid 24045623)
34. Tokars JI, Marcus R, Culver DH, et al. Surveillance of HIV infection and zidovudine use among healthcare workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group. Ann Intern Med 1993; 118:913-919. (Pubitemid 23164127)
35. Patz JA, Jodrey D. Occupational health in surgery: risks extend beyond the operating room. Aust N Z J Surg 1995; 65:627-629.
36. Kaplan EH, O'Keefe E. Let the needles do the talking! Evaluating the New Haven needle exchange. Interfaces 1993; 23:7-26.
37. Hudgens MG, Longini IM Jr, Vanichseni S, et al. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol 2002; 155:159-168. (Pubitemid 34072739)
38. Baggaley RF, Boily MC, White RG, Alary M. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and metaanalysis. AIDS 2006; 20:805-812. (Pubitemid 43731561)
39. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8:553-563.
40. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9:118-129.
41. Beyrer C. Hidden yet happening: the epidemics of sexually transmitted infections and HIV among men who have sex with men in developing countries. Sex Transm Infect 2008; 84:410-412.
42. Brookmeyer R, Gail MH. Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet 1986; 2:1320-1322. (Pubitemid 17177873)
43. Hallett TB, Zaba B, Todd J, et al. Estimating incidence from prevalence in generalised HIV epidemics: methods and validation. PLoS Med 2008; 5:e80.
44. Brown T, Bao L, Raftery AE, et al. Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009. Sex Transm Infect 2010; 86:ii3-ii10.
45. Brown T, Peerapatanapokin W. The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia. Sex Transm Infect 2004; 80 (Suppl 1):i19-i24. (Pubitemid 39070780)
46. Reidy WJ, Goodreau SM. The role of commercial sex venues in the HIV epidemic among men who have sex with men. Epidemiology 2010; 21:349-359.
47. Hoare A, Wilson DP, Regan DG, et al. Using mathematical modelling to help explain the differential increase in HIV incidence in New South Wales, Victoria and Queensland: importance of other sexually transmissible infections. Sex Health 2008; 5:169-187. (Pubitemid 351786454)
48. Karon JM, Song R, Brookmeyer R, et al. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results. Stat Med 2008; 27:4617-4633.
49. Adam PC, Teva I, de Wit JB. Balancing risk and pleasure: sexual self-control as a moderator of the influence of sexual desires on sexual risk-taking in men who have sex with men. Sex Transm Infect 2008; 84:463-467.
50. Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst 2005; 97:896-905. (Pubitemid 41417941)
51. Dukers NH, Renwick N, Prins M, et al. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 2000; 151:213-224. (Pubitemid 30463624)
52. Choi KH, Han CS, Hudes ES, Kegeles S. Unprotected sex and associated risk factors among young Asian and Pacific Islander men who have sex with men. AIDS Educ Prev 2002; 14:472-481. (Pubitemid 36008606)
53. Choi KH, Gibson DR, Han L, Guo Y. High levels of unprotected sex with men and women among men who have sex with men: a potential bridge of HIV transmission in Beijing, China. AIDS Educ Prev 2004; 16:19-30. (Pubitemid 38327322)
54. Crepaz N, Marks G, Liau A, et al. Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis. AIDS 2009; 23:1617-1629.
55. Reisen CA, Iracheta MA, Zea MC, et al. Sex in public and private settings among Latino MSM. AIDS Care Psychol Socio-med Aspects AIDS/HIV 2010; 22:697-704.
56. Hart GJ, Elford J. Sexual risk behaviour of men who have sex with men: emerging patterns and new challenges. Curr Opin Infect Dis 2010; 23:39-44.
57. Mao L, Crawford JM, Hospers HJ, et al. 'Serosorting' in casual anal sex of HIV-negative gay men is noteworthy and is increasing in Sydney, Australia. AIDS 2006; 20:1204-1206. (Pubitemid 43786112)
58. Suarez T, Miller J. Negotiating risks in context: a perspective on unprotected anal intercourse and barebacking among men who have sex with men: where do we go from here? Arch Sex Behav 2001; 30:287-300. (Pubitemid 33745565)
59. Suarez TP, Kelly JA, Pinkerton SD, et al. Influence of a partner's HIV serostatus, use of highly active antiretroviral therapy, and viral load on perceptions of sexual risk behavior in a community sample of men who have sex with men. J Acquir Immune Defic Syndr 2001; 28:471-477. (Pubitemid 34033200)
60. Elford J, Ibrahim F, Bukutu C, Anderson J. Sexual behaviour of people living with HIV in London: implications for HIV transmission. AIDS 2007; 21 (Suppl 1):S63-70. (Pubitemid 44967417)
61. Truong HM, Kellogg T, Klausner JD, et al. Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex Transm Infect 2006; 82:461-466. (Pubitemid 46025187)
62. Golden MR, Wood RW, Buskin SE, et al. Ongoing risk behavior among persons with HIV in medical care. AIDS Behav 2007; 11:726-735. (Pubitemid 47327576)
63. Elford J. Changing patterns of sexual behaviour in the era of highly active antiretroviral therapy. Curr Opin Infect Dis 2006; 19:26-32. (Pubitemid 43032436)
64. Xia Q, Molitor F, Osmond DH, et al. Knowledge of sexual partner's HIV serostatus and serosorting practices in a California population-based sample of men who have sex with men. AIDS 2006; 20:2081-2089. (Pubitemid 44611061)
65. Kippax S, Crawford J, Davis M, et al. Sustaining safe sex: a longitudinal study of a sample of homosexual men. AIDS 1993; 7:257-263. (Pubitemid 23091297)
66. Kippax S, Noble J, Prestage G, et al. Sexual negotiation in the AIDS era: negotiated safety revisited. AIDS 1997; 11:191-197. (Pubitemid 27055405)
67. Van de Ven P, Kippax S, Crawford J, et al. In a minority of gay men, sexual risk practice indicates strategic positioning for perceived risk reduction rather than unbridled sex. AIDS Care 2002; 14:471-480.
68. Tindall B, Swanson C, Donovan B, Cooper DA. Sexual practices and condom usage in a cohort of homosexual men in relation to human immunodeficiency virus status. Med J Aust 1989; 151:318-322. (Pubitemid 19238589)
69. Cassels S,Menza TW, GoodreauSM, GoldenMR. HIV serosorting as a harm reduction strategy: evidence from Seattle, Washington. AIDS 2009; 23:2497-2506.
70. Wilson DP, Regan DG, Heymer KJ, et al. Serosorting may increase the risk of HIV acquisition among men who have sex with men. Sex Transm Dis 2010; 37:13-17.
71. Wilson DP, Hoare A, Regan DG, Law MG. Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men. Sex Health 2009; 6:19-33.
72. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2008.
73. Johnston KM, Levy AR, Lima VD, et al. Expanding access to HAART: a costeffective approach for treating and preventing HIV. AIDS 2010; 24:1929-1935.
74. Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006; 368:531-536. (Pubitemid 44142776)
75. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010.
76. Desai K, Sansom SL, Ackers ML, et al. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. AIDS 2008; 22:1829-1839.
77. Ammaranond P, Cunningham P, Oelrichs R, et al. Rates of transmission of antiretroviral drug resistant strains of HIV-1. J Clin Virol 2003; 26:153-161. (Pubitemid 36206600)
78. Eshleman SH, Husnik M, Hudelson S, et al. Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. AIDS 2007; 21:1165-1174. (Pubitemid 46763287)
79. Marconi VC, Sunpath H, Lu Z, et al. Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa. Clin Infect Dis 2008; 46:1589-1597. (Pubitemid 351706742)
80. Little SJ, Holte S, Routy J-P, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002; 347:385-394. (Pubitemid 34851830)
81. Supervie V, Garcia-Lerma JG, Heneine W, Blower S. HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis. Proc Natl Acad Sci U S A 2010; 107:12381-12386.
82. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342:921-929. (Pubitemid 30177052)
83. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375:2092-2098.
84. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23:1397-1404.
85. Del Romero J, Castilla J, Hernando V, et al. Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. Br Med J 2010; 340:c2205.
86. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010; 5:e11068.
87. Fisher M, Pao D, Brown AE, et al. Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach. AIDS 2010; 24:1739-1747.
88. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 2004; 18:81-88. (Pubitemid 38402321)
89. Hallett TB, Smit C, Garnett GP, de Wolf F. Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners. Sex Transm Infect 2010.
90. Wilson DP, Law MG, Grulich AE, et al. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008; 372:314-320. (Pubitemid 352020440)
91. Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les personnes sé ropositives ne souffrant d'aucune autre MST et suivant un traitment antiré troviral efficace ne transmettent pas le VIH par voie sexuelle [HIV-positive individuals without additional sexually transmitted diseases (STD) and on effective anti-retroviral therapy are sexually non-infectious]. Bull Méd Suisses 2008; 89:165-169.
92. Smith RJ, Okano JT, Kahn JS, et al. Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco. Science 2010; 327:697-701.
93. Greenhalgh D, Hay G. Mathematical modelling of the spread of HIV/AIDS amongst injecting drug users. IMA J Math Appl Med Biol 1997; 14:11-38. (Pubitemid 127463788)
94. Blower SM, Hartel D, Dowlatabadi H, et al. Drugs, sex and HIV: a mathematical model for New York City. Philos Trans R Soc Lond B Biol Sci 1991; 331:171-187.
95. Murray JM, Law MG, Gao Z, Kaldor JM. The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. Int J Epidemiol 2003; 32:708-714. (Pubitemid 37304626)
96. Bacaë r N, Abdurahman X, Ye J. Modeling the HIV/AIDS epidemic among injecting drug users and sex workers in Kunming, China. Bull Mathematical Biol 2006; 68:525-550. (Pubitemid 44195560)
97. Vickerman P, Hickman M, Rhodes T, Watts C. Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users. J Acquir Immune Defic Syndr 2006; 42:355-361. (Pubitemid 44050015)
98. Siegel J, Weinstein M, Fineberg H. Bleach programs for preventing AIDS among iv drug users: modeling the impact of HIV prevalence. Am J Public Health 1991; 81:1273-1279.
99. Kretzschmar M, Wiessing L. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users. AIDS 2008; 22:1527-1537.
100. Sutton AJ, Gay NJ, Edmunds WJ. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. Vaccine 2006; 24:2377-2386. (Pubitemid 43290420)
101. Sutton AJ, Gay NJ, Edmunds WJ, et al. Modelling the hepatitis B vaccination programme in prisons. Epidemiol Infect 2006; 134:231-242. (Pubitemid 43280229)
102. Sutton AJ, Gay NJ, Edmunds WJ, et al. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infect Dis 2006; 6:93.
103. Kwon JA, Iversen J, Maher L, et al. The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis. J Acquir Immune Defic Syndr 2009; 51:462-469.
104. National Centre in HIV Epidemiology and Clinical Research. Return on investment 2: evaluating the cost-effectiveness of needle and syringe programs in Australia 2009. 2009, the University of New South Wales: Sydney.
105. Guinness L, Vickerman P, Quayyum Z, et al. The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh. Addiction 2010; 105:319-328.
106. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2010.